|
1
|
Smeby J, Sveen A, Merok MA, Danielsen SA,
Eilertsen IA, Guren MG, Dienstmann R, Nesbakken A and Lothe RA:
CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in
primary colorectal cancer. Ann Oncol. 29:1227–1234. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Somers E: International Agency for
Research on Cancer. Encyclopedia of Toxicology. 133:1067–1069.
2014.
|
|
3
|
Tauriello DV, Calon A, Lonardo E and
Batlle E: Determinants of metastatic competency in colorectal
cancer. Mol Oncol. 11:97–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang JP: Chinese standard for the
diagnosis and treatment of colorectal cancer (2010). Zhonghua Wei
Chang Wai Ke Za Zhi. 14:1–4. 2011.(In Chinese). PubMed/NCBI
|
|
5
|
Sepulveda AR, Hamilton SR, Allegra CJ,
Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C,
Lindor NM, Minsky BD, et al: Molecular biomarkers for the
evaluation of colorectal cancer: Guideline From the American
Society for Clinical Pathology, College of American Pathologists,
Association for Molecular Pathology, and American Society of
Clinical Oncology. J Clin Oncol. 35:1453–1486. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qiu X, Hu B, Huang Y, Deng Y, Wang X and
Zheng F: Hypermethylation of ACP1, BMP4, and TSPYL5 in
hepatocellular carcinoma and their potential clinical significance.
Dig Dis Sci. 61:149–157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vogel T, Dittrich O, Mehraein Y, Dechend
F, Schnieders F and Schmidtke J: Murine and human TSPYL genes:
Novel members of the TSPY-SET-NAP1L1 family. Cytogenet Cell Genet.
81:265–270. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Epping MT, Meijer LA, Krijgsman O, Bos JL,
Pandolfi PP and Bernards R: TSPYL5 suppresses p53 levels and
function by physical interaction with USP7. Nat Cell Biol.
13:102–108. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim EJ, Lee SY, Kim TR, Choi SI, Cho EW,
Kim KC and Kim IG: TSPYL5 is involved in cell growth and the
resistance to radiation in A549 cells via the regulation of
p21(WAF1/Cip1) and PTEN/AKT pathway. Biochem Biophys Res Commun.
392:448–453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jung Y, Park J, Bang YJ and Kim TY: Gene
silencing of TSPYL5 mediated by aberrant promoter methylation in
gastric cancers. Lab Invest. 88:153–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shao L, Shen Z, Qian H, Zhou S and Chen Y:
Knockdown of miR-629 Inhibits ovarian cancer malignant behaviors by
targeting testis-specific Y-like protein 5. DNA Cell Biol.
36:1108–1116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lyu JH, Park DW, Huang B, Kang SH, Lee SJ,
Lee C, Bae YS, Lee JG and Baek SH: RGS2 suppresses breast cancer
cell growth via a MCPIP1-dependent pathway. J Cell Biochem.
116:260–267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ansari SS, Sharma AK, Soni H, Ali DM, Tews
B, König R, Eibl H and Berger MR: Induction of ER and mitochondrial
stress by the alkylphosphocholine erufosine in oral squamous cell
carcinoma cells. Cell Death Dis. 9:2962018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khaket TP, Singh MP, Khan I, Bhardwaj M
and Kang SC: Targeting of cathepsin C induces autophagic
dysregulation that directs ER stress mediated cellular cytotoxicity
in colorectal cancer cells. Cell Signal. 46:92–102. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang F and Luo J: Endoplasmic reticulum
stress and ethanol neurotoxicity. Biomolecules. 5:2538–2553. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mishra RR, Belder N, Ansari SA, Kayhan M,
Bal H, Raza U, Ersan PG, Tokat ÜM, Eyüpoğlu E, Saatci Ö, et al:
Reactivation of cAMP pathway by PDE4D inhibition
represents a novel druggable axis for overcoming tamoxifen
resistance in ER-positive breast cancer. Clin Cancer Res.
24:1987–2001. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bakhtou H, Olfatbakhsh A, Deezagi A and
Ahangari G: The expression of dopamine receptors gene and their
potential role in targeting breast cancer cells with selective
agonist and antagonist drugs. Could it be the novel insight to
therapy? Curr Drug Discov Technol. 16:184–197. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Z, Zhang L, Gao M, Han M, Liu K, Zhang
Z, Gong Z, Xing L, Shi X, Lu K and Gao H: Endoplasmic reticulum
stress triggers Xanthoangelol-induced protective autophagy via
activation of JNK/c-Jun Axis in hepatocellular carcinoma. J Exp
Clin Cancer Res. 38:82019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma Z, Yang Y, Di S, Feng X, Liu D, Jiang
S, Hu W, Qin Z, Li Y, Lv J, et al: Pterostilbene exerts anticancer
activity on non-small-cell lung cancer via activating endoplasmic
reticulum stress. Sci Rep. 7:80912017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Gong W, Yang ZY, Zhou XS, Gong C,
Zhang TR, Wei X, Ma D, Ye F and Gao QL: Quercetin induces
protective autophagy and apoptosis through ER stress via the
p-STAT3/Bcl-2 axis in ovarian cancer. Apoptosis. 22:544–557. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ba-Omar TA, Al-Jardani S and Victor R:
Effects of pesticide temephos on the gills of Aphanius
dispar (Pisces: Cyprinodontidae). Tissue Cell. 43:29–38. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abe M, Yamashita S, Mori Y, Abe T, Saijo
H, Hoshi K, Ushijima T and Takato T: High-risk oral leukoplakia is
associated with aberrant promoter methylation of multiple genes.
BMC Cancer. 16:3502016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Witek Ł, Janikowski T, Bodzek P, Olejek A
and Mazurek U: Expression of tumor suppressor genes related to the
cell cycle in endometrial cancer patients. Adv Med Sci. 61:317–324.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lakshmanan I, Salfity S, Seshacharyulu P,
Rachagani S, Thomas A, Das S, Majhi PD, Nimmakayala RK, Vengoji R,
Lele SM, et al: MUC16 regulates TSPYL5 for lung cancer cell growth
and chemoresistance by suppressing p53. Clin Cancer Res.
23:3906–3917. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumar SR, Bryan JN, Esebua M,
Amos-Landgraf J and May TJ: Testis specific Y-like 5: Gene
expression, methylation and implications for drug sensitivity in
prostate carcinoma. BMC Cancer. 17:1582017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang C and Luo H: miR-19-5p enhances
tumorigenesis in human colorectal cancer cells by targeting TSPYL5.
DNA Cell Biol. 37:23–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakagawa T, Zhu H, Morishima N, Li E, Xu
J, Yankner BA and Yuan J: Caspase-12 mediates
endoplasmic-reticulum-specific apoptosis and cytotoxicity by
amyloid-beta. Nature. 403:98–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim IY, Shim MJ, Lee DM, Lee AR, Kim MA,
Yoon MJ, Kwon MR, Lee HI, Seo MJ, Choi YW and Choi KS: Loperamide
overcomes the resistance of colon cancer cells to bortezomib by
inducing CHOP-mediated paraptosis-like cell death. Biochem
Pharmacol. 162:41–54. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han X, Kang KA, Piao MJ, Zhen AX, Hyun YJ,
Kim HM, Ryu YS and Hyun JW: Shikonin exerts cytotoxic effects in
human colon cancers by inducing apoptotic cell death via the
endoplasmic reticulum and mitochondria-mediated pathways. Biomol
Ther (Seoul). 27:41–47. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Chen Y, Huang Q, Liu W, Ji X, Hu F,
Zhu Y, Zhang L and Dong G: IRAK2 counterbalances oncogenic Smurf1
in colon cancer cells by dictating ER stress. Cell Signal.
48:69–80. 2018. View Article : Google Scholar : PubMed/NCBI
|
